Diabetes and Frailty: Two Converging Conditions?

Canadian Journal of Diabetes

Volumn 40, Issue 1, 2016, Pages 77-83

  Sinclair, Alan J ^b,c   Rodriguez Mañas, Leocadio ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^b Foundation for Diabetes Research in Older People   (United Kingdom)

^c ASTON UNIVERSITY   (United Kingdom)

Author keywords

Diabetes; Frailty; Older people; Quality of life; Sarcopenia

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CYTOKINE; INSULIN;

AGING; CHRONIC DISEASE; COGNITIVE DEFECT; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOCRINE DISEASE; FRAIL ELDERLY; HUMAN; INFLAMMATION; INSULIN RESISTANCE; NUTRITION; OBESITY; REVIEW; SARCOPENIA; SOCIETY; STRESS; AGED; COGNITION DISORDERS; COGNITIVE AGING; COGNITIVE DYSFUNCTION; COMPLICATION; DELAYED DIAGNOSIS; DIABETES MELLITUS, TYPE 2; DIFFERENTIAL DIAGNOSIS; DISABLED PERSON; EARLY DIAGNOSIS; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PSYCHOLOGY; QUALITY OF LIFE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COGNITION DISORDERS; COGNITIVE AGING; COGNITIVE DYSFUNCTION; COMBINED MODALITY THERAPY; DELAYED DIAGNOSIS; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; DISABLED PERSONS; EARLY DIAGNOSIS; FRAIL ELDERLY; HUMANS; QUALITY OF LIFE; SARCOPENIA;

EID: 84960927050     PISSN: 14992671     EISSN: 23523840     Source Type: Journal    
DOI: 10.1016/j.jcjd.2015.09.004     Document Type: Review

References (73)

1. Wilson P.N.F. Epidemiology of diabetes in the elderly. Am J Med 1982, 80(Suppl. 15A):3-15.
2. Harris M.I., Hadden W.C., Knowler W.C., Bennett P.H. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20-74 years. Diabetes 1987, 36:523-534.
3. Manton K.G., Stallard E.S., Liu K. Forecasts of active life expectancy: Policy and fiscal implications. J Gerontol 1993, 48(special issue):11-26.
4. Resnick H.E., Harris M.I., Brock D.B., Harris T.B. American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: Results from the Third National Health and Nutrition Examination Survey. Diabetes Care 2000, 23:176-180.
5. Halter J.B. Diabetes mellitus in older adults: Underdiagnosis and undertreatment. J Am Geriatr Soc 2000, 48:340-341.
6. Narayan K.M., Boyle J.P., Thompson J. Lifetime risk for diabetes mellitus in the United States. JAMA 2003, 290:1884-1890.
7. Murray C.J., Lopez A.D. Measuring the global burden of disease. N Engl J Med 2013, 369:448-457.
8. Sloan F.A., Bethel M.A., Ruiz D., et al. The growing burden of diabetes mellitus in the US elderly population. Arch Intern Med 2008, 168:192-199.
9. Boyd C.M., Landefeld C.S., Counsell S.R., et al. Recovery of activities of daily living in older adults after hospitalization for acute medical illness. J Am Geriatr Soc 2008, 56:2171-2179.
10. Espeland M.A., Gill T.M., Guralnik J., et al. Designing clinical trials of interventions for mobility disability: Results from the Lifestyle Interventions and Independence for Elders Pilot (LIFE-P) trial. J Gerontol A Biol Sci Med Sci 2007, 62:1237-1243.
11. Pahor M., Guralnik J.M., Ambrosius W.T., et al. Effect of structured physical activity on prevention of major mobility disability in older adults: The LIFE study randomised clinical trial. JAMA 2014, 311:2387-2396. for the; LIFE Study investigators.
12. Fried L.P., Ferruci L., Darer J., et al. Understanding the concepts of disability, frailty and comorbidity: Implications for improved targeting and care. J Gerontol Biol Sci Med Sci 2004, 59:255-263.
13. Rodriguez-Mañas L., Fried L.P. Frailty in the clinical scenario. Lancet 2015, 385:e7-9.
14. Fried L.P., Kronmal R.A., Newman A.B., et al. Risk factors for 5-years mortality in older adults: The Cardiovascular Health Study. JAMA 1998, 279:585-592.
15. Collard R.M., Boter H., Schoevers R.A., Oude Voshaar R.C. Prevalence of frailty in community-dwelling older persons: A systematic review. J Am Geriatr Soc 2012, 60:1487-1492.
16. Kallman D.A., Plato C.C., Tobin J.D. The role of muscle loss in the age-related decline of grip strength: Cross-sectional and longitudinal perspectives. J Gerontol 1990, 45:M82-8.
17. Morley J.E., Baumgartner R.N., Roubenoff R., et al. Sarcopenia. J Lab Clin Med 2001, 137:231-243.
18. Kalyani R.R., Corriere M., Ferrucci L. Age-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol 2014, 2:819-829.
19. Meneilly G.S., Elahi D. Metabolic alterations in middle-aged and elderly lean patients with type 2 diabetes. Diabetes Care 2005, 28:1498-1499.
20. Wong E., Backholer K., Gearon E., et al. Diabetes and risk of physical disability in adults: A systematic review and meta-analysis. Lancet Diabetes Endocrinol 2013, 1:106-114.
21. Stotmeyer E.S., Cauley J.A., Schwartz A.V., et al. Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: The health, aging and body composition study. Arch Intern Med 2005, 165:1612-1617.
22. Mac Leod K.M., Tooke J.E. Direct and indirect costs of cardiovascular and cerebrovascular complications of type II diabetes. Pharmacoeconomics 1995, 8(Suppl. 1):46-51.
23. American Diabetes Association Standards of medical care in diabetes, 2015. Diabetes Care 2015, 38:S4(Suppl. 1).
24. Nicolls M.R. The clinical and biological relationship between type II diabetes mellitus and Alzheimer's disease. Curr Alzheimer Res 2004, 1:47-54.
25. García-Esquinas E., Graciani A., Guallar-Castillón P., et al. Diabetes and risk of frailty and its potential mechanisms: A prospective cohort study of older adults. J Am Med Dir Assoc 2015.
26. Sinclair A., Dunning T., Rodriguez-Mañas L. Diabetes in older people: New insights and remaining challenges. Lancet Diabetes Endocrinol 2015, 3:275-285.
27. Lourenço R.A., Pérez-Zepeda M., Gutiérrez-Robledo L., et al. Performance of the European Working Group on Sarcopenia in Older People: Algorithm in screening older adults for muscle mass assessment. Age Ageing 2015, 44:334-338.
28. Hughes V.A., Frontera E.R., Roubenoff R., et al. Longitudinal changes in body composition in older men and women: Role of body weight change and physical activity. Am J Clin Nutr 2002, 76:473-481.
29. McNeil C.J., Doherty T.J., Stashuk D.W., Rice C.L. Motor unit number estimates in the tibialis anterior muscle of young, old, and very old men. Muscle Nerve 2005, 31:461-467.
30. Cree M.G., Newcomer B.R., Katsanos C.S., et al. Intramuscular and liver triglycerides are increased in the elderly. J Clin Endocrinol Metab 2004, 89:3864-3871.
31. Giresi P.G., Stevenson E.J., Theilhaber J., et al. Identification of molecular signature of sarcopenia. Physiol Genomics 2005, 21:253-263.
32. Rolland Y., Czerwinski S., Abellan van Kan G., et al. Sarcopenia: Its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging 2008, 12:433-450.
33. Amigues I., Schott A.M., Amine M., et al. Low skeletal muscle mass and risk of functional decline in elderly community-dwelling women: The prospective EPIDOS study. J Am Med Dir Assoc 2013, 14:352-357.
34. Cesari M., Leeuenburgh C., Lauretani F., et al. Frailty syndrome and skeletal muscle: Result from the InCHIANTI study. Am J Clin Nutr 2006, 83:1142-1148.
35. Rodríguez-Mañas L., Féart C., Mann G., et al. Searching for an operational definition of frailty: A Delphi method based consensus statement: The frailty operative definition-consensus conference project. J Gerontol A Biol Sci Med Sci 2013, 68:62-67.
36. Fried L.P., Tangen C.M., Walston J., et al. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001, 56:M146-56.
37. Clegg A., Young J., Iliffe S., et al. Frailty in older people. Lancet 2013, 381:752-762.
38. Turnbull P.J., Sinclair A.J. Evaluation of nutritional status and its relationship with functional status in older citizens with diabetes mellitus using the mininutritional assessment (MNA) tool: A preliminary investigation. J Nutr Health Aging 2002, 6:185-189.
39. Matthew C., Robert C., Aaron S., et al. The prevalence of vitamin B12 deficiency in patients with type 2 diabetes: A cross-sectional study. J Am Board Fam Med 2009, 22:528-534.
40. Visvanathan R., McPhee I. Undernutrition and anorexia in the older person. Gastroenterol Clin North Am 2009, 38:393-409.
41. Cheung K., Luk A., So W., et al. Testosterone level in men with type 2 diabetes mellitus and related metabolic effects: A review of current evidence. Diabetes Investig 2015, 6:112-123.
42. Ozfirat Z., Tahseen A.C. Vitamin D deficiency and type 2 diabetes. Postgrad Med J 2010, 86:18-25.
43. Latham N.K., Anderson C.S., Reid I.R. Effects of vitamin D supplementation on strength, physical performance, and falls in older persons: A systematic review. J Am Geriatr Soc 2003, 51:1219-1226.
44. Shardell M., Hicks G.E., Miller R.R., et al. Association of low vitamin D levels with the frailty syndrome in men and women. J Gerontol A Biol Sci Med Sci 2009, 64A:69-75.
45. Serra-Prat M., Palomera E., Clave P., Puig-Domingo M. Effect of age and frailty on ghrelin and cholecystokinin responses to a meal test. Am J Clin Nutr 2009, 89:1410-1417.
46. Nomura T., Ikeda Y., Nakao S., et al. Muscle strength is a marker of insulin resistance in patients with type 2 diabetes: a pilot study. Endocrinol J 2007, 54:791-796.
47. Louard R.J., Fryburg D.A., Gelfand R.A., Barrett E.J. Insulin sensitivity of protein and glucose metabolism in human forearm skeletal muscle. J Clin Invest 1992, 90:2348-2354.
48. Newman E., Heslin M.J., Wolf R.F., et al. The effect of systemic hyperinsulinemia with concomitant amino acid infusion on skeletal muscle protein turnover in the human forearm. Metabolism 1994, 43:70-78.
49. Guttridge D.C. Signaling pathways weigh on decisions to make or break skeletal muscle. Curr Opin Clin Nutr Metab Care 2004, 7:443-450.
50. Payette H., Roubenoff R., Jacques P.F., et al. Insulin-like growth factor-1 and interleukin 6 predict sarcopenia in very old community-living men and women: The Framingham Heart Study. J Am Geriatr Soc 2003, 51:1237-1243.
51. Walston J., Arking D.E., Fallin D., et al. IL-6 gene variation is not associated with increased serum levels of IL-6, muscle, weakness, or frailty in older women. Exp Gerontol 2005, 40:344-352.
52. Visser M., Pahor M., Taeffe D.R., et al. Relationship of interleukin-6 and tumor necrosis factor-α with muscle mass and muscle strength in elderly men and women: The Health ABC Study. J Gerontol A Biol Sci Med Sci 2002, 57:M326-32.
53. García-Esquinas E., José García-García F., León-Muñoz L.M., et al. Obesity, fat distribution, and risk of frailty in two population-based cohorts of older adults in Spain. Obesity (Silver Spring) 2015, 23:847-855.
54. Kanaya A.M., Harris T., Goodpaster B.H., et al. Adipocytokines attenuate the association between visceral adiposity and diabetes in older adults. Diabetes Care 2004, 27:1375-1380.
55. Baumgartner R.N. Body composition in healthy aging. Ann N Y Acad Sci 2000, 904:437-448.
56. Payne G.W. Effect of inflammation on the aging microcirculation: Impact on skeletal muscle blood flow control. Microcirculation 2006, 13:343-352.
57. Petersen K.F., Befroy D., Dufour S., et al. Mitochondrial dysfunction in the elderly: Possible role in insulin resistance. Science 2003, 300:1140-1142.
58. Petersen K.F., Dufour S., Befroy D., et al. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004, 350:664-671.
59. De Rekeneire N., Resnick H.E., Shwartz A.V., et al. Diabetes is associated with subclinical functional limitation in nondisabled older individuals: The Health, Aging, and Body Composition study. Diabetes Care 2003, 26:3257-3263.
60. Allen M.D., Stashuk D.W., Kimpinski K., et al. Increased neuromuscular transmission instability and motor unit remodelling with diabetic neuropathy as assessed using novel near fibre motor unit potential parameters. Clin Neurophysiol 2015, 126:794-802.
61. Roshanravan B. Frailty in CKD: Is only seeing worth believing?. Am J Kidney Dis 2014, 64:489-491.
62. Rodríguez-Mañas L., Bouzon C.A., Castro M. Peripheral arterial disease in old people with diabetes. Diabetes in Old Age 2009, Wiley, Chichester, UK. 3rd edn. A.J. Sinclair (Ed.).
63. Samper-Ternent R., Al Snih S., Raji M.A., et al. Relationship between frailty and cognitive decline in older Mexican Americans. J Am Geriatr Soc 2008, 56:1845-1852.
64. Buchman A.S., Schneider J.A., Leurgans S., et al. Physical frailty in older persons is associated with Alzheimer disease pathology. Neurology 2008, 71:499-504.
65. Cheng G., Huang C., Deng H., Wang H. Diabetes as a risk factor for dementia and mild cognitive impairment: A meta-analysis of longitudinal studies. Intern Med J 2012, 42:484-491.
66. Whitmer R.A., Karter A.J., Yaffe K., et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009, 301:1565-1572.
67. Koekkoek P.S., Kappelle L.J., van den Berg E., et al. Cognitive function in patients with diabetes mellitus: Guidance for daily care. Lancet Neurol 2015, 14:329-340.
68. Roriz-Filho J.S., Sá-Rodriguez T.M., Rosset I., et al. Pre)diabetes, brain aging, and cognition. Biochim Biophys Acta 2009, 1792:432-443.
69. Pasquier F., Boulogne A., Leys D., Fontaine P. Diabetes mellitus and dementia. Diabetes Metab 2006, 32:403-414.
70. Monte S.M., Wands J.R. Alzheimer's disease is type 3-evidence reviewed. J Diabetes Sci Technol 2008, 2:1101-1113.
71. Kuusisto J., Koivisto K., Mykkanen L., et al. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: Cross-sectional population-based study. BMJ 1997, 315:1045-1049.
72. Hsiung G.Y., Sadovnik A.D., Feldman H. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: Data from the Canadian Study of Health and Aging. Can Med Assoc J 2004, 171:863-867.
73. Rodríguez-Mañas L., Bayer A.J., Kelly M., et al. An evaluation of the effectiveness of a multi-modal intervention in frail and pre-frail older people with type 2 diabetes: The MID-Frail study: Study protocol for a randomised controlled trial. Trials 2014, 15:34.